Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
International Seaways
INSW
$5.74B
| $3.05M | ﹤0.01% |
62,737
+3,568
| +6% | +$176K |
2016 Q4
36 quarters
|
|
2602
ProPetro Holding
PUMP
$1.14B
| $3.04M | ﹤0.01% |
319,772
+31,449
| +11% | +$273K |
2017 Q1
35 quarters
|
|
2603
Crane NXT
CXT
$2.81B
| $3.04M | ﹤0.01% |
64,606
-5,632
| -8% | -$333K |
2013 Q2
50 quarters
|
|
2604
Corvus Pharmaceuticals
CRVS
$917M
| $3.04M | ﹤0.01% |
394,766
+85,614
| +28% | +$675K |
2016 Q3
37 quarters
|
|
|
ETHA
2605
CALL
iShares Ethereum Trust ETF
ETHA
$9.8B
| $3.03M | ﹤0.01% |
135,300
-164,700
| -55% | -$4.31M |
2025 Q3
1 quarter
|
|
2606
Graphic Packaging
GPK
$2.6B
| $3.03M | ﹤0.01% |
201,385
-114,120
| -36% | -$1.88M |
2013 Q2
50 quarters
|
|
2607
Origin Bancorp
OBK
$1.65B
| $3.03M | ﹤0.01% |
80,588
+14,622
| +22% | +$524K |
2018 Q2
30 quarters
|
|
2608
Procept Biorobotics
PRCT
$983M
| $3.03M | ﹤0.01% |
96,329
+18,658
| +24% | +$619K |
2022 Q1
15 quarters
|
|
2609
Buckle
BKE
$2.21B
| $3.03M | ﹤0.01% |
56,692
-9,808
| -15% | -$547K |
2013 Q2
50 quarters
|
|
2610
PUT
Clorox
CLX
$9.72B
| $3.02M | ﹤0.01% |
+30,000
| New | +$3.26M |
2025 Q4
0 quarters
|
|
2611
MasterBrand
MBC
$1.43B
| $3.02M | ﹤0.01% |
273,380
+50,536
| +23% | +$592K |
2022 Q4
12 quarters
|
|
2612
Skyward Specialty Insurance
SKWD
$2.44B
| $3.01M | ﹤0.01% |
58,880
+7,376
| +14% | +$355K |
2023 Q1
11 quarters
|
|
2613
Boston Beer
SAM
$1.72B
| $3M | ﹤0.01% |
15,398
-1,699
| -10% | -$350K |
2013 Q2
50 quarters
|
|
2614
US Treasury 6 Month Bill ETF
XBIL
$754M
| $3M | ﹤0.01% |
+60,000
| New | +$3.01M |
2025 Q4
0 quarters
|
|
|
EA
2615
PUT
DELISTED
Electronic Arts
EA
| $3M | ﹤0.01% |
14,700
| – | – |
2025 Q3
1 quarter
|
|
2616
CALL
Boston Scientific
BSX
$61.7B
| $3M | ﹤0.01% |
31,500
| – | – |
2024 Q2
6 quarters
|
|
2617
Artivion
AORT
$1.09B
| $3M | ﹤0.01% |
65,703
+11,087
| +20% | +$494K |
2016 Q3
37 quarters
|
|
2618
Element Solutions
ESI
$9.24B
| $2.99M | ﹤0.01% |
119,784
+8,487
| +8% | +$220K |
2015 Q2
42 quarters
|
|
2619
Intuitive Machines
LUNR
$2.37B
| $2.99M | ﹤0.01% |
184,333
+30,238
| +20% | +$350K |
2024 Q2
6 quarters
|
|
2620
Horace Mann Educators
HMN
$1.83B
| $2.98M | ﹤0.01% |
64,515
+6,888
| +12% | +$312K |
2013 Q2
50 quarters
|
|
2621
PUT
Bank OZK
OZK
$5.09B
| $2.97M | ﹤0.01% |
+64,600
| New | +$3.02M |
2025 Q4
0 quarters
|
|
2622
Aurinia Pharmaceuticals
AUPH
$2.11B
| $2.97M | ﹤0.01% |
186,140
+14,540
| +8% | +$206K |
2019 Q1
27 quarters
|
|
|
ALEX
2623
DELISTED
Alexander & Baldwin
ALEX
| $2.97M | ﹤0.01% |
143,786
-25,620
| -15% | -$445K |
2013 Q2
50 quarters
|
|
2624
Photronics
PLAB
$1.86B
| $2.96M | ﹤0.01% |
92,618
+6,890
| +8% | +$178K |
2013 Q2
50 quarters
|
|
2625
Coastal Financial
CCB
$614M
| $2.95M | ﹤0.01% |
25,781
+5,920
| +30% | +$646K |
2018 Q3
29 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.